Thank you for attending THSNA 2026. The virtual meeting is now closed.
Use this page to browse all contributing authors.
Presentations for Karin Fijn van Draat
FRONTIER3: Safety and efficacy of Mim8 prophylaxis in pediatric patients with hemophilia A |
Patient- and caregiver-reported outcomes with subcutaneous Mim8 prophylaxis in pediatric patients with hemophilia A with or without factor VIII inhibitors: phase 3 FRONTIER3 study |